EGFR Antibody from NKMAX Co. Ltd.
Search, find, compare suppliers for anti-EGFR antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | EGFR |
| Clone | AT2H8 |
| Host Species | Mouse |
| Reactive Species | human |
| Isotype | IgG2b kappa |
| Format | Protein A purified |
| Size | 50ul, 100ul |
| Concentration | 1mg/ml (determined by BCA assay) |
| Applications | ELISA, WB, ICC/IF |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Epidermal growth factor receptor (EGFR) is a 170 kDa membrane protein first identified as a bindingpartner of EGF. Also, EGFR phosphorylated itself (autophosphorylation) in response to EGF treatment. Theoverexpression of EGFR in various epithelial tumors was widely reported and it has been substantiated thatderegulation of EGFR itself and its signaling pathways an important role in human cancers. |
| Immunogen | Recombinant human EGFR (424-605aa) purified from E. coli |
| Other Names | ERBB, ERBB1, Epidermal growth factor receptor, HER1, PIG61, epidermal growth factor receptor,Urogastrone, Proto-oncogene c-ErbB-1, Oncogene ERBB, Cell proliferation inducing protein 61, Cellgrowth inhibiting protein 40, Avian erythroblastic leukemia viral (verbb) oncogene homolog |
| Gene, Accession # | NCBI: NP_005219, UniProt: P00533 |
| Catalog # | ATGA0541 |
| Price | $190, $320 |
| Order / More Info | EGFR Antibody from NKMAX Co. Ltd. |
| Product Specific References | Tran AV, et al. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers. (Acta Biomater. 2018){https://pubmed.ncbi.nlm.nih.gov/29775731/};;Tran VA, et al. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells. (Int J Nanomedicine. 2020) {https://pubmed.ncbi.nlm.nih.gov/33116494/} |
NKMAX Co. Ltd.
NKMAX Co. Ltd.
6F, SNUH Health Care Innovation Park
172 Dolma-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13605 REPUBLIC OF KOREA
P: +82-31-8017-8114
F: +82-31-8017-8124
salesbio@nkmax.com
http://www.nkmaxbio.com
Profile of NKMAX Co. Ltd.